NO931697L - Lhrh-antagonister - Google Patents

Lhrh-antagonister

Info

Publication number
NO931697L
NO931697L NO93931697A NO931697A NO931697L NO 931697 L NO931697 L NO 931697L NO 93931697 A NO93931697 A NO 93931697A NO 931697 A NO931697 A NO 931697A NO 931697 L NO931697 L NO 931697L
Authority
NO
Norway
Prior art keywords
parent compound
dala
nac
leu
pro
Prior art date
Application number
NO93931697A
Other languages
English (en)
Other versions
NO931697D0 (no
Inventor
Shabo Tianjin Xiao
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of NO931697D0 publication Critical patent/NO931697D0/no
Publication of NO931697L publication Critical patent/NO931697L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

To antagonister er beskrevet: 1) fremgangsmåten for konstruksjon og syntese av LHRH-antagonister; 2) produkter oppnådd deretter ved anvendelse av ovennevnte fremgangsmåte. Med (NaC-daNal1, DpCIPhe2, D3Pal3, Ser4, Tyr5, DArg6, Leu7, Arg3, Pro9, Dala10)NE2 som foreldreforbindelse, en serie nye analoger uttrykt som (NAc-D2Xal1, ÅA2, ÅA3, Ser4, ÅA5, ÅA6, Leu7, ÅA3, Pro9, Dala10)NH2 blir oppnådd ved- finmodifikasjon av både lipofile områder og alkaliske områder av molekylet til foreldreforbindelsen. På denne måten kan den høye antiovulatorlske aktiviteten til foreldreforbindelsen bli opprettholdt og den histaminfrigjørende aktiviteten kan bli redusert til et nivå for å oppfølge det kliniske kravet.
NO93931697A 1990-11-10 1993-05-10 Lhrh-antagonister NO931697L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN90108955A CN1036343C (zh) 1990-11-10 1990-11-10 新促黄体生成素释放激素拮抗类似物的制备方法
PCT/EP1991/002110 WO1992008733A1 (en) 1990-11-10 1991-11-08 Lhrh-antagonists

Publications (2)

Publication Number Publication Date
NO931697D0 NO931697D0 (no) 1993-05-10
NO931697L true NO931697L (no) 1993-07-07

Family

ID=4881223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931697A NO931697L (no) 1990-11-10 1993-05-10 Lhrh-antagonister

Country Status (29)

Country Link
EP (1) EP0564466B1 (no)
KR (1) KR100244624B1 (no)
CN (1) CN1036343C (no)
AT (1) ATE149520T1 (no)
AU (1) AU662496B2 (no)
CA (1) CA2095932C (no)
CZ (1) CZ284168B6 (no)
DE (1) DE69125024T2 (no)
DK (1) DK0564466T3 (no)
EE (1) EE03141B1 (no)
ES (1) ES2100965T3 (no)
FI (1) FI933156A (no)
GR (1) GR3023389T3 (no)
HR (1) HRP920585B1 (no)
IE (1) IE913915A1 (no)
LT (1) LT3971B (no)
LV (1) LV10106B (no)
NO (1) NO931697L (no)
NZ (1) NZ240505A (no)
PH (1) PH31178A (no)
PL (1) PL170564B1 (no)
PT (1) PT99458B (no)
RU (1) RU2123499C1 (no)
SI (1) SI9111779B (no)
SK (1) SK281319B6 (no)
UA (1) UA41300C2 (no)
WO (1) WO1992008733A1 (no)
YU (1) YU48831B (no)
ZA (1) ZA918847B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3568952B2 (ja) * 1992-12-18 2004-09-22 アボット・ラボラトリーズ ５位及び６位に修飾アミノアシル残基を有するｌｈｒｈ拮抗薬
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
DE4338015A1 (de) * 1993-11-08 1995-05-11 Asta Medica Ag Verwendung von D-glucopyranuronsäuren und deren Derivaten zum Einbau in pharmakologisch wirksame Peptide und deren Salze
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
CN102675418B (zh) * 2011-03-15 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物、其制备方法及用途
CN103524599B (zh) * 2012-07-05 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 环肽lhrh拮抗剂衍生物及其药物用途
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity

Also Published As

Publication number Publication date
HRP920585B1 (en) 2000-08-31
CZ84893A3 (en) 1994-02-16
PH31178A (en) 1998-03-20
DE69125024D1 (de) 1997-04-10
LV10106A (lv) 1994-05-10
NO931697D0 (no) 1993-05-10
ES2100965T3 (es) 1997-07-01
DE69125024T2 (de) 1997-07-17
EE03141B1 (et) 1998-12-15
EP0564466A1 (en) 1993-10-13
SI9111779B (en) 2001-12-31
CA2095932A1 (en) 1992-05-11
FI933156A0 (fi) 1993-07-09
YU177991A (sh) 1994-06-24
IE913915A1 (en) 1992-05-20
CN1061605A (zh) 1992-06-03
NZ240505A (en) 1993-04-28
LT3971B (en) 1996-05-27
DK0564466T3 (da) 1997-08-25
HRP920585A2 (en) 1997-04-30
EP0564466B1 (en) 1997-03-05
PL295427A1 (en) 1993-09-06
CZ284168B6 (cs) 1998-09-16
SK45393A3 (en) 1993-10-06
CA2095932C (en) 2003-02-25
PT99458B (pt) 1999-02-26
KR930703353A (ko) 1993-11-29
SI9111779A (en) 1997-04-30
SK281319B6 (sk) 2001-02-12
AU8861291A (en) 1992-06-11
UA41300C2 (uk) 2001-09-17
WO1992008733A1 (en) 1992-05-29
AU662496B2 (en) 1995-09-07
YU48831B (sh) 2002-03-18
LV10106B (en) 1995-04-20
FI933156A (fi) 1993-07-09
KR100244624B1 (ko) 2000-02-15
GR3023389T3 (en) 1997-08-29
ATE149520T1 (de) 1997-03-15
PL170564B1 (pl) 1996-12-31
ZA918847B (en) 1992-08-26
RU2123499C1 (ru) 1998-12-20
CN1036343C (zh) 1997-11-05
PT99458A (pt) 1992-10-30
LTIP1513A (en) 1995-06-26

Similar Documents

Publication Publication Date Title
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
EA199800559A1 (ru) Антагонисты гонадотропин-высвобождающего фактора
EA199800564A1 (ru) Антагонисты гонадотропин-высвобождающего фактора
ATE149520T1 (de) Lhrh-antagonisten
DE69331721T2 (de) Neue carbamazepin hapten Analoge
CO5011087A1 (es) Antagonistas de receptores de vitronectina
RU93004994A (ru) Продукты, применение и способ получения антагонистов гормона, стимулирующего выделение лютеинизирующего гормона
ES2037709T3 (es) Derivados heterociclicos de seis miembros de n,n'-diacilhidrazinas n'-sustituidas.
ES2080621T3 (es) Preparacion de uso cutaneo.
ES2089548T3 (es) Benzhidrilaminas sustituidas como agentes de conexion para sintesis de peptidos en fase solida.
SE8704240D0 (sv) Analgesic preparations
IT1204664B (it) Macchina spruzzatrice principalmente per la dispersione di soluzione di spruzzatura proporzionatamente all'area
TR200002293T2 (tr) Farmasötik bileşimler.
ES2191753T3 (es) Antagonistas de lhrh.
OA09197A (fr) "Peptides SDK, leur procédé de préparation ainsi que des compositions thérapeutiques en contenant".
ATE37376T1 (de) Nonapeptid- und decapeptidanaloge von lhrh mit wirkung als lhrh antagonisten, ihre herstellung und diese enthaltende zusammensetzungen.
RU92009228A (ru) Пептидный антагонист тиролиберина
DE59009367D1 (de) Vasopressin-Analoga,ihre Herstellung und ihre pharmazeutische Verwendung.
TH9794EX (th) อนุพันธ์ต่าง ๆ ของ 4-ซับสทิทิวเทด พิราโซโล[3,4,-d] พิริมิดีน
ITMI920891A0 (it) Procedimento per la realizzazione di ciabatte e di calzature aperte, nonche' calzature ottenute in base allo stesso

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application